İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
Welltower Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $164.9B | |
|---|---|---|
| Revenue (ttm) | 13.8B | |
| Net income (ttm) | 1.7B | |
| EPS (ttm) | $2.32 | |
| Shares out | 733.6M | |
| P/E (trailing) | 97.8x | |
| P/E (forward) | 77.5x | |
| Dividend | $3.40 (1.50%) | |
| Volume | 4,867,974 | |
| Beta | 0.75 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.20B | $4.17B | $4.75B | $6.03B | $8.45B | +27.5% |
| Gross profit | $1.93B | $2.22B | $2.53B | $3.02B | $4.18B | +21.2% |
| Operating income | $660.6M | $702.6M | $957.9M | $1.10B | $171.9M | -28.6% |
| Net income | $336.1M | $141.2M | $340.1M | $951.7M | $936.8M | +29.2% |
| EPS (diluted) | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 | +15.5% |
| EBITDA | $1.71B | $2.04B | $2.40B | $2.78B | $2.31B | +7.8% |
| R&D | $0 | $0 | $0 | — | — | +11.8% |
| SG&A | $126.7M | $150.4M | $179.1M | $235.5M | $1.75B | +92.7% |
Recent company headlines from major financial publishers.
The base path projects steady occupancy recovery across senior housing facilities, with annual resident rate increases offsetting labor expenses. Contractual rental income from triple-net and outpatient properties provides cash flow stability, leading to an intrinsic target of $73.89 representing an expected return of -68.3% with probability 60.0%.
The bull path envisions accelerating senior housing occupancy exceeding pre-pandemic peaks, coupled with double-digit RevPOR growth that drives operating margins above historical norms. Capital deployment via accretive acquisitions further enhances cash generation, yielding an intrinsic target of $82.97 and an expected return of -64.4% with probability 20.0%.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.1% | $111 | $113 | $116 | $120 | $125 |
| 7.1% | $87.4 | $88.9 | $90.6 | $92.8 | $95.6 |
| 8.1% | $71.8 | $72.7 | $73.9 | $75.3 | $77.0 |
| 9.1% | $61.3 | $62.0 | $62.8 | $63.7 | $64.9 |
| 10.1% | $53.3 | $53.8 | $54.4 | $55.1 | $55.9 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
